Keywords
cognitive disorders
emotional disorders
anxiety
How to Cite
Abstract
At all stages of development of somatic disease, one of the most significant factors influencing the clinical picture and the nature of the disease is the mental state of the patient. It is known that the basis of psychosomatic disorders, which include type II diabetes, are emotional disorders that adversely affect psychosomatic pathology and can not only provoke its occurrence, but also lead to recurrence of psychosomatic disease. A comprehensive clinical, psychopathological and psychodiagnostic examination of 82 patients with moderate type 2 diabetes mellitus (46 women and 36 men) aged (35.9±10.1) years was perfomed, in compliance with the principles of bioethics and deontology. The study of cognitive functions by Mini-mental State Examination (MMSE) revealed mild (51.2%) or moderate (49.8%) cognitive impairment in examined patients, on average in the group examined the overall score by the MMSE Scale was (25.2±0.2) points. The conducted psychodiagnostic study showed an increase in the level of situational [(55.7±6.1) points] and personal anxiety [(54.5±6.4) points] by the Spielberger-Khanin Scale. 65.8% of the examined patients had a mild episode, 11.5% had a moderate depressive episode, and 56.1% of the examined patients had a mild, 40.3% moderate anxiety episode by the Hamilton Anxiety Rating Scale. The examined patients are characterized by a high level of emotional stress, anxiety, asthenic symptom complex and hypochondriac manifestations.
Keywords: type II diabetes mellitus, cognitive disorders, emotional disorders, anxiety.
References
Mokrii V.Ya., Ziablitsev S.V., Kryshtal M.V. (2016). Osoblyvosti formuvannia okysnoho stresu u khvorykh na tsukrovyi diabet 2-ho typu zalezhno vid tryvalosti zakhvoriuvannia ta stati [Peculiarities of oxidative stress formation in patients with type 2 diabetes mellitus depending on the duration of the disease and sex]. Mizhnarodnyi endokrynolohichnyi zhurnal – International Endocrinological Journal, No. 5, pp. 67–71 [in Ukrainian].
Radchenko O.M., Koroliuk O.Ya., Syroid M.V. (2003). Osoblyvosti perebihu tsukrovoho diabetu pry riznykh typakh zahalnykh nespetsyfichnykh adaptatsiinykh reaktsii [Peculiarities of diabetes mellitus in different types of general nonspecific adaptive reactions]. Halytskyi likarskyi visnyk – Galician Medical Bulletin, No. 3, pp. 68–71 [in Ukrainian].
Mykhailov B.V. (2017). Secondary depression in pationts with cardiovascular and cerebrovascular diseases. Psychiatry, psechotherapy and clinical psychology, No. 8 (1), pp. 64–69.
Korostii V.I, Parovina H.V. (2015). Robota Tsentru psykhosomatyky, psykhoterapii ta medyko-psykholohichnoi reabilitatsii v universytetskii klinitsi KhNMU yak model multdystsyplinarnoho pidkhodu [Work of the Center of psychosomatics, psychotherapy and medical-psychological rehabilitation in the university clinic of KhNMU as a model of multidisciplinary approach]. Ukrainskyi visnyk psykhonevrolohii – Ukrainian Bulletin of Psychoneurology, vol. 23, No. 2 (83), pp.111–112 [in Ukrainian].
Zemlianitsyna O., Polozova L., Karachentsev I., Sinaiko V., Kravchun N. (2018). Features of excretion of melatonin in urine in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease with manifestations of fibrosis and its relationship with certain metabolic and immunological indicators. Georgian Medical News, 1 (274), pp. 103–107.
Kozhyna H.M., Markova M.V., Chuhunov V.V., Kurylo V.O., Tkachenko O.V., Danilevska N.V. et al. (2020). Osoblyvosti struktury ta rozpovsiudzhenosti astenii v strukturi tsukrovoho diabetu 2-ho typu sered khvorykh riznykh sotsialnykh hrup [Peculiarities of the structure and prevalence of asthenia in the structure of type 2 diabetes mellitus among patients of different social groups]. Problemy endokrynnoi patolohii – Problems of endocrine pathology, 2 (72), pp. 89–94 [in Ukrainian].
Zherdova N.M. (2016). Stan kohnityvnoi funktsii ta depresyvnykh rozladiv u khvorykh na tsukrovyi diabet 2-ho typu zriloho viku zalezhno vid vydu tsukroznyzhuvalnoi terapii [The state of cognitive function and depressive disorders in patients with type 2 diabetes mellitus of adulthood, depending on the type of antidiabetic therapy]. Endokrynolohiia – Endocrinology, vol. 21 (4), pp. 350–355 [in Ukrainian].
Hatskykh Y.V., Veselova O.F., Brykman Y.N., Shalda T.P., Adamian R.A., Petrova M.M. (2015). Kognitivnyye narusheniya pri sakharnom diabete 2 tipa [Cognitive impairments in type 2 diabetes mellitus]. Sovremennyye problemy nauki i obrazovaniya – Modern problems of science and education, No.4, Retrieved from http://www.science-education.ru/ru/article/view?id=20805 [in Russian].
Pashkovska N.V. (2018). Kohnityvni porushennia pry tsukrovomu diabeti typu 2: rol hipohlikemizuiuchoi terapii [Cognitive impairment in type 2 diabetes mellitus: the role of hypoglycemic therapy]. Mizhnarodnyi endokrynolohichnyi zhurnal – International Journal of Endocrinology, No.1, pp. 76–85 [in Ukrainian].
Biessels G.J., Deary I.J., Ryan C.M. (2008). Cognition and diabetes: a lifespan perspective. The Lancet Neurology, vol. 7, No.2, pp. 184–190.
Brundel M., van den Heuvel M., de Bresser J., Kappelle L.J., Biessels G.J. (2010). Cerebral cortical thickness in patients with type 2 diabetes. Utrecht Diabetic Encephalopathy Study Group. Journal of the neurological sciences, vol. 299 (1), pp. 126–130.